AMYLOID, the ISA Journal

In 1987 the number of amyloid publications had increased rapidly from 1950 to 1986. At the symposium in Japan, Thomas Muckle discussed the need for an autonomous journal for amyloidosis. In 1994 the first issue of AMYLOID was published! AMYLOID: The Journal of Protein Folding Disorders covers all aspects of the protein groups, amyloidoses and other protein folding disorders.



AMYLOID: The Journal of Protein Folding Disorders is the official journal of the International Society of Amyloidosis. The Journal was established in 1994 as AMYLOID: The International Journal of Experimental & Clinical Investigation until the change of name in 2004. Impact factor in 2011 was 2.660. Ranking: 161/290(Q3; Biochemistry & Molecular Biology), 43/112(Q2; Medicine, Research & Experimental), and 26/155 (Q1; Medicine, General & Internal).

Journal information: AMYLOID is dedicated to the study of all aspects of the protein groups and associated disorders that are classified as the amyloidoses as well as other disorders associated with abnormal protein folding. The Journal has a major focus on etiology, pathogenesis, histopathology, chemical structure and the nature of fibrillogenesis and also publishes papers on the genetic aspects (both basic and clinical) of many of these disorders.

AMYLOID is recognised as one of the leaders in the publication of the classification of the amyloid proteins and the associated disorders as well as clinical studies of all aspects of the amyloid related neurodegenerative diseases and major clinical studies on the inherited amyloidosis, especially those related to transthyretin. The Journal also publishes Book Reviews, Meeting Reports, Editorials, Thesis Abstracts, Review Articles and Symposia in the various areas listed above.

It has been recommended to basic scientists, students of the neurodegenerative disorders (neurologists), histopathologists, geneticists and to a broad spectrum of clinicians, whose specialties are impacted by various amyloid diseases.


Practical issues:


Investigators may become Member of the ISA and can subscribe in one of three categories:

    Online only ($ 190.00): annual dues ($ 90.00) and e-journal subscription only ($ 100.00)

    Print & Online ($ 230.00): annual dues ($ 90.00) and both paper & e-journal subscription ($ 140.00)

    Young Investigator ($ 90.00) for investigators under age 35: dues ($ 20.00) and e-journal ($ 70.00)

All payments must be in U.S. Dollars.


Top reasons to submit to AMYLOID:

Rapid Publication: Your final article is published online in as little as 8 weeks, via our Early Online feature

Online Manuscript Submission: Submit and track the progress of your paper on our online submission site

Citation Alerts: Track citations to your article via our citation alert service


Instruction for authors

Submit your paper online

Editor-in-Chief: Prof. Per Westermark - Uppsala University, Uppsala, Sweden




Dr. Alan Cohen, MD.

Dr. Alan Cohen was the Founding Editor and from 1994 until 2010 the first Editor-in-Chief of Amyloid: The Journal of Protein Folding Disorders.  He is a Distinguished Professor of Medicine in Rheumatology at Boston University School of Medicine. Dr. Cohen began his research in amyloidosis while a fellow in Rheumatology at the Massachusetts General Hospital at the urging of Dr. Evan Calkins.  He isolated amyloid as a specific and unique fibrous protein, achieved its high resolution characterization for the first time with the electron microscope, and reported it at the First International Symposium on Amyloidosis, held in Groningen, The Netherlands in September, 1967.  He conducted biochemical studies on the relationship of the amyloid fibril to other proteins, carbohydrates, GAGs, and lipids, as well as immunological and protein sequence studies that led to the definition of amyloid types.  Reports from Dr. Cohen and his colleagues have been made at every subsequent International Symposium on Amyloidosis.